Login

Healthcare

00:00:00
ReNeuron Group's phase IIb stroke trial kicks off with first patient treated - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
ReNeuron / Michael Hunt, Chief Financial Officer, ReNeuron Group
00:00:00
Company update and season’s greetings from Regeneus Dec 2020 - Karolis Rosickas, CEO, Regeneus Ltd
00:00:00
Regeneus ASX:RGS May 2021 Business Update - Karolis Rosickas, CEO, Regeneus Ltd
00:00:00
Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
RedX Pharma drug candidate pipeline underpins strong first half progress - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma begins testing lead drug in phase II trial for idiopathic pulmonary fibrosis - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008 - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Redx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz Pharma - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
RedHill Biopharma (NASDAQ: RDHL) Presenting the company - Gay Goldberg, CBO, Redhill Biopharma Ltd
00:00:00
ReWalk Robotics Ltd RWLK CEO Larry Jasinski
00:00:00
RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global
00:00:00
Saniona President and CEO Rami Levin provides an overview of near-term milestones for key clinical programs - Rami Levin, CEO, Saniona
00:00:00
SELLAS Life Sciences Group - Licensed Asset Aims To Prolong Survival in Cancer Patients - Dr. Angelos Stergiou, President and CEO of SELLAS Life Sciences Group
00:00:00
Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma
00:00:00
Jonas Ekblom, CEO, Promore Pharma

© 2026 Nehu